Showing results (331-340 of 422) with videos related to

Sort By:
Pageof 43
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 30, 2020
Effectiveness and safety of dupilumab for the treatment of severe asthma in a real-life French multi-centre adult cohortClairelyne Dupin, Drifa Belhadi, Laurent Guilleminault, et al.
Circulation|April 25, 2023
Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial HypertensionChristophe Guignabert, Laurent Savale, Athénaïs Boucly, et al.
Chest|September 26, 2020
Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin CMarie-Caroline Certain, Marie-Camille Chaumais, Xavier Jaïs, et al.
ERJ Open Research|November 19, 2025
Economic impact of steroid-induced comorbidities in severe asthma: a SHARP CRC simulationBarbara Mascialino, Aruna T Bansal, Elisabeth Bel, et al.
Circulation|March 28, 2012
Pulmonary arterial hypertension in patients treated by dasatinibDavid Montani, Emmanuel Bergot, Sven Günther, et al.
Annals of the Rheumatic Diseases|August 8, 2025
Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitisPeter A Merkel, Parameswaran K Nair, Nader Khalidi, et al.
American Journal of Respiratory and Critical Care Medicine|March 14, 2019
Poor Concordance between Sequential Transbronchial Lung Cryobiopsy and Surgical Lung Biopsy in the Diagnosis of Diffuse Interstitial Lung DiseasesMicaela Romagnoli, Thomas V Colby, Jean-Philippe Berthet, et al.
Therapie|January 14, 2025
Organoids, organs-on-chips, complex in vitro model: Definitions, applications, validation, ethicsGuillaume Mottet, Alexandre Grassart, Philippe Barthélemy, et al.
The European Respiratory Journal|December 22, 2022
Identifying and appraising outcome measures for severe asthma: a systematic reviewAnna Rattu, Ekaterina Khaleva, Chris Brightling, et al.
Pageof 43